This makes sense in many ways and could be good if PYC had more than one 'active' collaboration. They say they have more, but really nothing happening with many of them for a long time, so am deeply skeptical.
Would be happy to take note if anyone has a different take on their current deal status...?
I am also increasingly concerned that since validating a break through of significance with the endosomal escape trap tech, then doing a deal with Jansen, then announcing another deal of some note there has been next to no reaction by the market. Just 1.75m shares traded over the last 9 trading days for a total market turnover of $34,417 or just $3,824 per day on average.
Does this seem like a company doing big things and going places?
It begs the question: Just what is going on over at PYC? Is the science just hype with no substance or is there almost a complete failure to market / commercialise the tech to the benefit of shareholders?
Admittedly it is only a matter of weeks since they've validated the tech, got their report from Griffin, etc... so maybe there are great things to come but the silence and muted market reaction is not inspiring confidence. Really hoping SOMETHING (positive) happens...sooner than later...
PYC Price at posting:
1.9¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)